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The simple hypothesis about angiogenesis as a prognostic marker
is that the intratumoural, leaky vessels may allow the tumour cells
to reach the blood stream, and thus increase the metastatic poten-
tial and probability of fatal outcome for the patient. This mecha-
nistic explanation may be a simplification of a more complex
process, in which the perfusion effect coexists with a paracrine
action of the vessels, regulated by growth factors and proteolytic
enzymes (Folkman, 1995), modulating the interaction of the
stromal component and the tumour cells into a more aggressive
metastasizing growth pattern.
Several studies, including nearly 4000 patients, have evaluated
intratumoural vessel profiles as a prognostic variable in breast
cancer (Bosari et al, 1992; Hall et al, 1992; Horak et al, 1992;
Weidner et al, 1992; Khanuja et al, 1993; Toi et al, 1993, 1995;
Van Hoef et al, 1993; Fox et al, 1994, 1995b; Fregene et al, 1994;
Gasparini et al, 1994, 1995; Lipponen et al, 1994; Obermair et al,
1994, 1995; Axelsson et al, 1995; Barbareschi et al, 1995;
Bevilacqua et al, 1995; Costello et al, 1995; Goulding et al, 1995;
Ogawa et al, 1995; Heimann et al, 1996; Kohlberger et al, 1996;
Leek et al, 1996; Morphopoulos et al, 1996; Simpson et al, 1996;
Charpin et al, 1997; Karelia et al, 1997; Martin et al, 1997;
Acenero et al, 1998). However, these studies have reported contra-
dictory results, without reliable evidence allowing for the clinical
use of angiogenesis as a prognostic factor in breast cancer. In addi-
tion to the frequently small number of included patients per obser-
vational follow-up study, there are differences between studies
mainly concerning the applied techniques and the selection of
study populations, making comparable analysis of prognostic
information difficult. Some authors have discussed the problems
of sample size (Harrell et al, 1985; Simon and Altman, 1994),
suggesting as a rule of thumb that the number of events should at
least be ten times the number of included variables. However, to
make the inference reasonable to the general population, the
composition of the study population may be just as important as
the sample size. A robust inception cohort will be achieved by
including all patients in a predefined geographical area and during
a defined period.
Ideally a prognosticator should be simple, inexpensive and easy
to perform apart from providing independent prognostic value.
Vascular grading was introduced by Fox et al (1995a) and is a
simple method to estimate the degree of tumour angiogenesis. The
loss of information by categorization into three groups is compen-
sated by the short period of evaluation per tumour, which is 
attractive in a clinical setup. Awareness should be given to the
reproducibility, because of the subjectivity of this grading system.
However, this is a general problem associated with methods
assessing angiogenesis by immunohistochemically stained vessel
profiles (Hansen et al, 1998).
Knowledge about clinical relevance and application, apart from
the statistical significance in a scientific context, is crucial in the
evaluation of any prognostic factor. Prognostic indices, calculated
from the contribution of relevant variables, provide the individual
patient with a prognostic score. A new prognostic variable has
clinical impact for patients only when the changes in the prog-
nostic index estimate have consequences for the clinical decision
process. However, the clinical decision process may be a hetero-
Vascular grading of angiogenesis: prognostic
significance in breast cancer
S Hansen1,5, DA Grabau2,5, FB Sørensen4, M Bak2, W Vach3 and C Rose1,5
Departments of 1Oncology, 2Pathology and 3Statistics and Demography, Odense University Hospital, DK-5000 Odense C, Denmark; 4Department of Pathology,
Aarhus County Hospital, Aarhus University Hospital, DK-8000 Aarhus C, Denmark; 5Oncological Research Centre, Kløvervænget 10-5, Odense University, DK-
5000 Odense C, Denmark
Summary The study aimed to evaluate the prognostic value of angiogenesis by vascular grading of primary breast tumours, and to evaluate
the prognostic impact of adding the vascular grade to the Nottingham Prognostic Index (NPI). The investigation included 836 patients. The
median follow-up time was 11 years and 4 months. The microvessels were immunohistochemically stained by antibodies against CD34.
Angiogenesis was graded semiquantitatively by subjective scoring into three groups according to the expected number of microvessels in the
most vascular tumour area. The vascular grading between observers was moderately reproduced (k = 0.59). Vascular grade was significantly
associated with axillary node involvement, tumour size, malignancy grade, oestrogen receptor status and histological type. In univariate
analyses vascular grade significantly predicted recurrence free survival and overall survival for all patients (P < 0.0001), node-negative
patients (P < 0.0001) and node-positive patients (P < 0.0001). Cox multivariate regression analysis showed that vascular grading contributed
with independent prognostic value in all patients (P < 0.0001). A prognostic index including the vascular grade had clinical impact for 24% of
the patients, who had a shift in prognostic group, as compared to NPI, and implied a better prognostic dissemination. We concluded that the
angiogenesis determined by vascular grading has independent prognostic value of clinical relevance for patients with breast cancer. © 2000
Cancer Research Campaign
Keywords: breast-neoplasms; CD34; neovascularization; observer-variation; prognosis; survival-analysis
339
British Journal of Cancer (2000) 82(2), 339–347
© 2000 Cancer Research Campaign
Article no. bjoc.1999.0924
Received 28 September 1998
Revised 21 April 1999
Accepted 13 May 1999
Correspondence to: S Hansengeneous matter. The Nottingham Prognostic Index (NPI) is a vali-
dated index (Haybittle et al, 1982; Todd et al, 1987; Galea et al,
1992; Balslev et al, 1994), that has led to clinically useful
grouping of breast cancer patients, based solely on tumour size,
lymph node state and histological grading of malignancy. Thus, it
can be used as a validated predefined tool for clinical decisions in
order to investigate the accompanying clinical relevance of a new
prognostic factor, i.e. the new prognostic index must spread the
survival probabilities of the population to a higher degree.
The aim of the present study was to evaluate the prognostic
value of angiogenesis by vascular grading in a large group of
breast cancer patients. The reproducibility of the vascular grading
technique was examined in a subset of the patients. The prognostic
examination was performed by estimating the independent prog-
nostic value of the vascular grading. The accompanying clinical
relevance was evaluated by the impact of vascular grading on the
prognostic stratification of the patients, compared with what is
comprised by the NPI alone.
MATERIALS AND METHODS
Sampling of patients
This study was based on the complete population of patients with
the diagnosis of breast cancer from a certain geographical area.
The region was the primary catchment area of Odense University
Hospital, where the patients were operated from 1 January 1980 to
31 December 1990. The inclusion criterion was patients with a
primary, unilateral, operable invasive breast carcinoma. The
exclusion criteria were patients with distant metastasis at the time
of diagnosis, locally advanced disease, inflammatory carcinoma,
synchronous bilateral breast cancer and a diagnosis of isolated
carcinoma in situ. Women with previous malignant disease, apart
from carcinoma in situ of the cervical uterus or skin cancer, were
also excluded, as were women who had not had at least one lymph
node removed at axillary dissection. Mammographic screening for
breast cancer was not performed in the background population
during this period. Surgery, adjuvant chemotherapy and radio-
therapy were carried out according to the nationwide recommen-
dation of the Danish Breast Cancer Cooperative Group (DBCG)
(Andersen and Mouridsen, 1988).
Number of patients
Of the 1252 women admitted with the suspected diagnosis of
breast cancer, the inclusion criterion selected 841 patients. In five
patients there was no tumour material available in the archives,
leaving 836 patients for the angiogenesis analysis.
A reduced study population (n = 535) was used in the analysis
that compared the prognostic impact of NPI with that provided by
vascular grading, which was comparable to those patients used in
the Nottingham study (Haybittle et al, 1982; Galea et al, 1992).
The selection followed the same criteria as in another Danish
study that evaluated the NPI (Balslev et al, 1994). Apart from the
presence of primary operable breast cancer, the criteria restricted
the subset to patients who had had three or more lymph nodes
removed from the axilla, who had tumours with histological
malignancy grading (i.e. ductal carcinoma, not otherwise speci-
fied) and whose age was less than 70 years, such that finally 535
patients was eligible for the comparative analysis. The NPI is
defined as: tumour size (in cm) ´ 0.2 + malignancy grade (1–3) +
lymph node status (1–3); lymph node status is 1 if the patients
have no metastasis, 2 if one to three metastatic nodes, and 3 if four
or more metastatic lymph nodes were detected in the axilla (Galea
et al, 1992; Balslev et al, 1994). Grading of histological malig-
nancy followed the grading system of Bloom and Richardson
(1957) and WHO guidelines (Scharff and Torloni, 1968).
Follow-up
Clinical records from departments at which the patients were
followed up, and pathology records from Odense University
Hospital were reviewed. Patients were followed regularly for 10
years at the Odense University Hospital, according to the DBCG
recommendation (Andersen and Mouridsen, 1988), although some
older patients were followed by their general practitioner and
referred to hospital if recurrence was suspected. Twenty patients
moved to other parts of the country. For those patients, the depart-
ments providing the follow-up if recurrence was suspected were
contacted, and the follow-up information was obtained from clin-
ical records. Two patients moved out of the country and were lost
to follow-up. Those patients were censored at the time of the last
contact. All the other patients were followed until the closing date
of the study, 31 October 1996, or until death, when earlier. The
patient recruitment took place over 11 years, and follow-up
continued for a further 5 years and 10 months. The maximum
possible observed survival times are therefore 16 years and 10
months for the initial patients, and 5 years and 10 months for the
last patients. The potential median follow-up time was 11 years
and 4 months (136 months).
End points
The analyses were performed for recurrence-free survival (RFS)
and overall survival (OS). The corresponding end points were
calculated as the period from surgery to the first recurrence at any
site (RFS), or death from any cause (OS). Of the 836 patients, 312
had recurrence, and 381 had died. The evaluation of NPI was
performed on OS, as in the study from which the index was
derived (Haybittle et al, 1982).
Immunohistochemistry
All archival blocks from each tumour were initially checked by
haematoxylin and eosin-stained sections to select a tumour block
with an invasive carcinoma, including the tumour border and as
large a cross-sectional area as possible. One 4-mm thick section
from each formalin-fixed and paraffin-embedded tumour was
mounted on a ChemMate slide (Dako, Denmark). Epitope retrieval
for CD34 was performed by microwave heating in 675 ml 10 mM
Tris + 0.5 mM EGTA buffer, pH 9, for 25 min with 600 W, cooling
in the buffer for 15 min, and rinsing in water for 5 min. The
immunostaining procedure was automated, using the ChemMate
Peroxidase/DAB kit on the TechMate 1000 instrument (Dako,
Denmark). As primary antibody against CD34 we used clone
QBEnd/10 (NovoCastra, UK) diluted 1:20 with overnight incuba-
tion at 4°C. The primary antibody against the oestrogen receptor
(ER) was clone ER1D5 (Dako, Denmark) diluted 1:200 with
overnight incubation at 4°C, which was preceded by epitope
retrieval by microwave heating with citrate buffer, pH 6. Negative
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each batch a positive control was produced by adding a section
with numerous vessel profiles and an oestrogen-positive receptor
section respectively.
Determination of angiogenesis by vascular grading
The amount of immunohistochemically highlighted microvessel
profiles were subjectively categorized by vascular grading. The
generally accepted criteria for determining a vessel profile
(Weidner et al, 1991) were used, including any stained endothelial
cell or endothelial-cell cluster that was separate from adjacent
microvessels. Vessel lumens were not required for identifying a
structure as a microvessel. Microvessels in necrotic or sclerotic
areas within a tumour and immediately adjacent areas of unaf-
fected breast tissue were not considered in vessel evaluations. One
observer performed the vascular grading by scanning the tumour
section at low magnifications, ´4 and ´10 objective lens, thereby
finding three separately located tumour areas, where the highest
number of discrete microvessels were stained (hot-spots). Each
hot-spot area was equivalent to a high power field with a ´25
objective lens and field diameter 0.50 mm. The vascular grading is
both influenced by the number of vessel profiles in the initial scan-
ning for hot-spots and by the area of the vessel profiles within the
hot-spots in the successive grading process. Thus, given an area
with high activity of angiogenesis by many microvessels, the
vessel profiles with a larger cross-sectional area or perimeter will
contribute more to a high vascular grade. Grade 1 (low angio-
genesis) was registered when the combined area of the three hot-
spots contained a low amount of endothelial stained microvessel
profiles. Grade 1 is typically assigned to tumours without any
actual hot-spots. Grade 2 (intermediate angiogenesis) was regis-
tered when the combined area of the three hot-spots contained a
moderate amount of vessel profiles. Grade 2 is typically assigned
to tumours with one very vascular hot-spot and two hot-spots with
only a low amount of microvessels. Grade 3 (high angiogenesis)
was registered when the combined area of the three hot-spots had
numerous vessel profiles with an average large area or perimeter
of vessel profiles. Our technique of vascular grading was thus very
similar to that of Fox et al (1995a), who initially introduced us to
the vascular grading. The determination of angiogenesis was
performed without knowledge of the prognostic outcome. About
one minute was used for vascular grading per tumour (Figure 1).
The reproducibility of the vascular grading was investigated
within and between observers. Forty tumours from the initial part
of the large material were selected representing the entire measure-
ment scale with 13, 13 and 14 tumours from grades 1, 2 and 3
respectively. The first observer graded the tumours twice at an
interval of 1 month, and the second observer graded the same
tumours once without knowledge of the first observer’s grading.
Statistics
The reproducibility of the vascular grading was evaluated by
kappa statistics. The association of vascular grading with other
variables was tested by the Spearman correlation test for ordinal
variables and the c2-test for nominal variables. The univariate rela-
tionship between the investigated prognostic parameters and
follow-up end-points was illustrated by Kaplan–Meier plots for
survival probabilities (Kaplan and Meier, 1958). The differences
between survival functions were compared by the log-rank test.
The multivariate relationship was evaluated by the Cox propor-
tional hazards regression analysis (Cox, 1972). Proportional
hazard rates were graphically controlled by log-minus-log-
survival plots from the multivariate analysed data stratified by the
controlled variable. The ER status did not have proportional
hazard rates to fulfil the assumption for the Cox model, hence we
stratified the Cox models by ER status. The Cox models were
developed by conventional backward selection procedure using a
Estimating angiogenesis by vascular grading 341
British Journal of Cancer (2000) 82(2), 339–347 © 2000 Cancer Research Campaign
0.50 mm
Figure 1 Examples of three hot-spots with low (A), intermediate (B) and
high (C) angiogenesis. The vascular grade of the tumour would be
intermediate or grade 2, if the three hot-spots were from the same tumourremoval limit of 10% based on the P-value from the likelihood
ratio statistics. The risk of the categorical covariates was estimated
in relation to a reference category, which was always the ‘lowest’
category. Age was an exception, for which the reference was the
40–49 age group, because the category of patients less than 40
years was rather limited in number. The significance of the addi-
tional prognostic value of vascular grade to NPI was assessed by a
likelihood ratio test. The NPI cut-off points from the initial study
were used (Haybittle et al, 1982). The Vascular grade Prognostic
Index (VPI) cut-off points were defined to be the level, where the
included number of patients in each category was the same as that
for the NPI alone. Calculations were performed with SPSS 7.5
(SPSS Inc.)
RESULTS
Reproducibility of vascular grading
The distributions of reproducibility data within and between
observers are shown in Table 1. Within observer, ten tumours were
classified in another grade, but only one had a shift of two grades.
Between observers, 11 tumours were classified in another grade,
but none had a shift of more than one group. Kappa-statistics with
95% confidence interval (CI) showed within observer k = 0.62
(0.41–0.83) and between observers k = 0.59 (0.37–0.81).
Clinico-pathological data
Table 2 shows the distribution of clinico-pathological characteris-
tics of patients in the study population, and the distribution of
vascular grade within the subgroups defined by the different char-
acteristics. Of the 836 patients with immunohistochemically
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Table 2 Description of clinico-pathological data and associated distribution of vascular grade
Characteristic All Vascular grade Association
n (%) 1 2 3 P-valuea
All patients 836 (100) 392 (47) 229 (27) 215 (26)
Age (years)
< 40 52 (6) 29 (56) 13 (25) 10 (19) 0.085
40–49 182 (22) 83 (46) 58 (32) 41 (22)
50–59 197 (23) 98 (50) 49 (25) 50 (25)
60–69 199 (24) 93 (47) 55 (27) 51 (26)
³ 70 206 (25) 89 (43) 54 (26) 63 (31)
Menopausal status
Premenopausal 315 (38) 158 (50) 87 (28) 70 (22) 0.072
Postmenopausal 521 (62) 234 (45) 142 (27) 145 (28)
Lymph node status
None 400 (48) 207 (52) 110 (27) 83 (21) <0.001
1–3 277 (33) 132 (48) 72 (26) 73 (26)
³ 4 159 (19) 53 (33) 47 (30) 59 (37)
Tumour size (mm)
≤ 20 420 (50) 235 (56) 108 (26) 77 (18) <0.001
21–50 361 (43) 135 (38) 106 (29) 120 (33)
> 50 55 (7) 22 (40) 15 (27) 18 (33)
Malignancy grade
I 140 (17) 99 (71) 28 (20) 13 (9) <0.001
II 316 (38) 155 (49) 98 (31) 63 (20)
III 251 (30) 61 (24) 77 (31) 113 (45)
Other 129 (15) 77 (60) 26 (20) 26 (20)
Histological type
Ductal 709 (85) 316 (44) 204 (29) 189 (27) 0.004
Lobular 91 (11) 59 (65) 18 (20) 14 (15)
Special 36 (4) 17 (47) 7 (20) 12 (33)
Oestrogen receptor
Negative 198 (24) 45 (23) 59 (30) 94 (47) <0.001
Positive 638 (76) 347 (54) 170 (27) 121 (19)
Surgery
Mastectomy 724 (87) 328 (45) 204 (28) 192 (27) 0.028
Lumpectomy 112 (13) 64 (57) 25 (22) 23 (21)
Adjuvant treatment
Chemotherapy 162 (19) 69 (43) 47 (29) 46 (28) 0.222
Endocrine therapy 139 (17) 59 (42) 44 (32) 36 (26) 0.413
Combination 32 (4) 13 (41) 8 (25) 11 (34) 0.319
Radiation therapy 350 (42) 162 (46) 95 (27) 93 (27) 0.680
aSpearman’s correlation test for the ordinal variables and the c2-test for the nominal clinico-pathological variables associated with the vascular
grading. Median (range): age 59 years (24–93 years), metastatic lymph nodes 2 (1–47), and of tumour size 20 mm (1–120 mm).
Table 1 Reproducibility data of the vascular grading
Within observer Between observer
1st observer, 2nd scoring 2nd observer
123 1 2 3
11 21 1 1 2 13
2652 2 7 4 13
3 1 13 3 11 14
19 6 15 13 12 15
k = 0.62 k = 0.59
95% CI 0.41–0.83 95% CI 0.37–0.81
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gstained tumours, 392 (47%) had vascular grade 1, 229 (27%) grade
2, and 215 (26%) grade 3. High vascular grading was significantly
associated with high numbers of axillary lymph node metastases,
large tumour size, high malignancy grade and ER-negative
tumours. There was also a significant association with histological
type, where the lobular carcinoma had many tumours of vascular
grade one. The association with the type of surgery did also reach
significance, where the smaller tumours after a lumpectomy more
often were of vascular grade one. Thus, the median (range) tumour
size after mastectomy was 22 mm (1–120 mm), and 15 mm (5–45
mm) after lumpectomy, which was significantly lower (P <
0.0001; Mann–Whitney test). Patients with high age and those
being post-menopausal had a tendency to have tumours with
higher vascular grades, although these associations were not
significant. By contrast, the vascular grading was not related to
treatment.
Univariate analysis
The univariate analysis showed that high vascular grade was a
significant indicator of poor prognosis for both RFS and OS
(Figure 2), P < 0.0001. This relation was documented in both the
node-negative (P < 0.0001) and node-positive (P < 0.0001)
patients. The 5- and 10-year survival probability for node-nega-
tive, node-positive and all patients is listed in Table 3 for each
level of vascular grading.
Apart from vascular grading, the univariate analysis also
showed that the prognosis was significantly worsened by a high
number of axillary metastatic nodes (P < 0.0001 for both RFS and
OS), by large tumour size (P < 0.0001, both RFS and OS), by high
malignancy grade (P < 0.0001, both RFS and OS), by high age 
(P < 0.0001, both RFS and OS), for post-menopausal patients 
(P < 0.0001, both RFS and OS), and for ER-negative patients 
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Figure 2 Kaplan–Meier plots of RFS (A) and OS (B) from the univariate analyses, illustrating the significant differences in survival probabilities between
patients with tumours of vascular grades (VG) one, two and three; n = 836
Table 3 The recurrence free survival (RFS) and overall survival (OS) probabilities ± s.e.m. in % 5 and 10
years after the diagnosis
Vascular No. RFS (%) OS (%)
grade of
patients 5-year 10-year 5-year 10-year
All patients (n = 836)
1 392 83 ± 2 72 ± 2 86 ± 2 72 ± 2
2 229 63 ± 3 51 ± 4 71 ± 3 52 ± 3
3 215 52 ± 4 49 ± 4 55 ± 3 39 ± 4
Node-negative patients (n = 400)
1 207 88 ± 2 84 ± 3 92 ± 2 81 ± 3
2 110 70 ± 4 61 ± 5 81 ± 4 60 ± 5
3 83 70 ± 5 66 ± 6 71 ± 5 59 ± 6
Node-positive patients (n = 436)
1 185 77 ± 3 60 ± 4 80 ± 3 62 ± 4
2 119 57 ± 5 41 ± 5 62 ± 4 44 ± 5
3 132 41 ± 4 38 ± 5 45 ± 4 27 ± 4(P = 0.0018, RFS; P = 0.0059, OS). The histological type was not
a significant prognostic factor.
Multivariate analysis of vascular grade
The initial Cox model, including all variables mentioned in Table
2, showed that the vascular grade had a statistically significant
overall prognostic value (P < 0.0001) independent of all the other
variables, and second only to axillary lymph node metastasses in
prognostic strength. In this model the risk of dying was 1.71 (95%
CI 1.31–2.22) higher with vascular grade 2, and 2.34 (95% CI
1.79–3.05) higher with vascular grade 3, compared with vascular
grade 1 and 1.37 (95% CI 1.06–1.77) higher risk with vascular
grade 3, compared with vascular grade 2.
Table 4 shows the final model from the Cox multivariate
analysis, containing the parameters with significant independent
prognostic value. The variables excluded from the initial model
during the backward selection procedure were: menopausal status
(pre vs post), histological type (ductal vs lobular or special), adju-
vant systemic treatment (none vs given), and radiation therapy
(none vs given). An independent prognostic value for both RFS
and OS, with increased risk, was demonstrated by a high number
of axillary lymph node metastases, large tumour size, high malig-
nancy grade and high age. Young age, less than 40 years, was esti-
mated to have a significantly higher risk of recurrence than the
40–49 age group, while the over 70-year-olds did not have a
significantly increased risk of recurrence.
The independent prognostic value of the vascular grade was
persistent in the subset of node-negative patients, but the risk esti-
mates of vascular grades 2 and 3 were now of the same magnitude.
Analysing RFS, the hazard ratios and 95% CI for the vascular
grade 2 were 2.27 (95% CI 1.42–3.64), and for grade 3 were 1.89
(95% CI 1.09–3.30). Tumour size was the only other significant
factor to predict recurrence in addition to the vascular grade.
Analysing OS, the hazard ratios and 95% CI for the vascular grade
2 were 1.79 (95% CI 1.19–2.70), and for grade 3 were 1.82 (95%
CI 1.15–2.88). In addition to the vascular grade, the age, and the
malignancy grades II and III were the only other significant prog-
nostic factors to predict OS in the node-negative patients. With
respect to the node-positive subgroup the same calculations
showed that for RFS, the hazard ratios and 95% CI for the vascular
grade 2 were 1.80 (95% CI 1.25–2.58), and for grade 3 were 2.64
(95% CI 1.84–3.79). Analysing OS, the hazard ratios and 95% CI
for the vascular grade 2 were 1.63 (95% CI 1.16–2.29), and for
grade 3 were 2.58 (95% CI 1.85–3.61). The malignancy grade had
no significant prognostic value, while number of metastatic lymph
nodes, tumour size and age, were of significant prognostic impact
for both RFS and OS.
Angiogenesis in relation to the NPI
The NPI is able to split patients with breast cancer into three
groups with significantly different prognosis (Haybittle et al,
1982; Galea et al, 1992). Figure 3 shows the OS probabilities in
the three NPI-groups, and of the three vascular grades in the
reduced study group (n = 535). The independent prognostic value
given by the Cox analysis for the OS could also be shown in the
reduced study population. Repeating all analyses, the same vari-
ables were significant, and the risk estimates were of the same
magnitude (results not shown).
Table 5 shows a Cox model with NPI alone (model A) and
combined with the vascular grade (model B), both providing
significant prediction of prognosis. The data was fitted signifi-
cantly better by model B than in model A (P < 0.0001). The
vascular grade thus added independent prognostic value to that
provided by the NPI alone, and a combined index 0.54´NPI +
0.45´vascular grade could be built. As both effects are of similar
magnitude, we suggest to use simply the new index:
The VPI value was calculated for the individual patient. The
patients were then divided into three groups, each with a number
of patients of comparable size to that of the three corresponding
isolated NPI groups. In Table 6, the two index groups are cross-
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Table 4 The Cox multivariate analysis estimated the independent prognostic values by hazard ratios (HR) and 95% CI for both recurrence free
survival (RFS) and overall survival (OS)
RFS OS
Variables Categories P-value HR (95% CI) P-value HR (95% CI)
Age (years) 40–49 0.0158 1.00 <0.0001 1.00
< 40 1.73 (1.04–2.88) 1.11 (0.61–2.04)
50–59 1.68 (1.19–2.38) 1.92 (1.34–2.77)
60–69 1.74 (1.23–2.46) 2.31 (1.61–3.31)
³ 70 1.41 (0.99–2.02) 4.27 (3.05–5.98)
Lymph node status None <0.0001 1.00 <0.0001 1.00
1–3 1.40 (1.06–1.85) 1.37 (1.07–1.76)
³ 4 3.57 (2.66–4.81) 3.55 (2.71–4.63)
Tumour size per cm 0.0009 1.12 (1.05–1.19) 0.0062 1.09 (1.02–1.16)
Malignancy grade Grade I, ductal 0.1915 1.00 0.0493 1.00
Grade II, ductal 1.52 (1.00–2.31) 1.57 (1.08–2.28)
Grade III, ductal 1.60 (1.01–2.53) 1.80 (1.19–2.74)
Non-ductal 1.61 (0.99–2.60) 1.50 (0.98–2.31)
Vascular grade Grade 1 <0.0001 1.00 <0.0001 1.00
Grade 2 1.92 (1.45–2.55) 1.70 (1.31–2.20)
Grade 3 2.40 (1.78–3.24) 2.32 (1.77–3.03)
The variables are presented as indicators with risk estimates relative to the basic category, where the risk is set to one, e.g. basic category for age is
40–49 years. P-values for the single variables are shown at the baseline category. All 836 patients are included.
Vascular Grade Prognostic Index (VPI) = NPI + Vascular Gradetabulated, showing that 31 patients from NPI group one were
removed to VPI group two, and that the 35 new patients included
in VPI group one were taken from NPI group two. If group one is
used to decide not to offer adjuvant treatment and group two to do
so, as suggested by the Nottingham group (Galea et al, 1992), then
the treatment decision would be changed by incorporating vascular
grade in the above example for 66 patients. In particular, 31
patients previously treated would now receive no treatment, and
35 patients previously not treated would receive treatment. The
exchange between the second and third groups was of the same
magnitude. A total of 24% of the patients (31+35+32+32) changed
prognostic group. Figure 4 illustrates the gain in prognostic
discrimination going from NPI to VPI. The patients in group one
selected by the VPI showed a somewhat better survival than the
comparable group selected by the NPI. Furthermore, VPI group
three had a poorer prognosis than NPI group three.
DISCUSSION
Our study focuses on three objectives. First, the reliability of
vascular grading to assess angiogenesis in breast carcinomas.
Second, the prognostic value of the vascular grade in breast carci-
nomas. Third, the practical clinical relevance of introducing the
prognostic value of the vascular grade, compared with therapeutic
decisions based on the predefined prognostic algorithm of the NPI.
Reproducibility of vascular grading
Assessing angiogenesis by vascular grading is attractive because it
takes about 1 min per slide. However, the drawbacks are loss of
information due to categorization, and only a moderate repro-
ducibility due to subjectivity, just like other hot-spot techniques
for assessing angiogenesis (Hansen et al, 1998). The grading
approach with three groups has been used earlier (Fox et al,
1995a), although the definitions of classifications may be slightly
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Figure 3 Kaplan–Meier plots of overall survival probabilities in the three
vascular grades (VG), and in the three Nottingham Prognostic Index groups
(NPI). n = 535 for both variables. This study population included patients less
than 70 years, who had had three or more lymph nodes removed from the
axilla, and who had a malignancy grading assigned to their tumours (i.e.
ductal carcinoma, not otherwise specified)
Table 5 Cox multivariate analysis including Nottingham Prognostic Index
(NPI) and vascular grade
Model A Model B
Variables b P b P
NPI (continuous) 0.61 <0.0001 0.54 <0.0001
Vascular grade (1 vs 2 vs 3) – – 0.45 <0.0001
–2 log likelihood 2292.6 2266.2
Difference (A vs B) 26.4
P-value; c2-test (A vs B) < 0.0001
Highly significant regression coefficients (b) were obtained for both variables,
and model B had a significantly better prediction of prognosis than that
provided by model A alone. (535 patients analysed).
Table 6 Cross-tabulation of NPI-groups and VPI-groups, showing the
exchange of patients by adding the independent prognostic value from the
vascular grade to that of the NPI
123
1 132 31 163
2 35 183 32 250
3 32 90 122
167 246 122 535
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Figure 4 Kaplan–Meier plot comparing the overall survival probabilities
from patients in the three groups of the Vascular grade Prognostic Index
(VPI) with the three groups of the Nottingham Prognostic Index (NPI). It was
intended to have the same number of patients in group one for both
variables, although not the same patients. The same constraints apply for
groups two and three. n = 535 for both variables
N
P
I
VPIdifferent. The present evaluation documented a substantial
intraobserver reproducibility, k = 0.62, and a moderate inter-
observer reproducibility, k = 0.59, representing an acceptable
reproducibility (Landis and Koch, 1977; Svanholm et al, 1989).
Other workers have previously reported substantial intraobserver
reproducibility, k = 0.66, by using only two grades (Fox et al,
1997). Using the same design of categorizing the present data, by
comparing grade 1 plus 2 with grade 3 we obtained an optimized
intraobserver reproducibility, k = 0.84.
Another method for estimating angiogenesis is by the Chalkley
count technique. The vascular grade has previously been related to
the Chalkley count, P = 0.001 (Fox et al, 1995a). The Chalkley
count by using a 25-point ocular grid has a more objective classifi-
cation criteria for the categorizing of for example three groups,
and therefore may be a more reliable method to introduce into
routine practice. On the other hand, the Chalkley count has also
been shown to have only a moderate reproducibility due to the
initial subjective selection of the hot-spot areas (Hansen et al,
1998). Furthermore, the prognostic value of the vascular grade is
not necessarily related to the prognostic value of the Chalkley
count, and it is therefore of interest to estimate the prognostic
value of the vascular grade, which has not been published before.
The archival material was stored in paraffin after varying fixa-
tion times, which were unlikely to influence the estimates. In the
pilot studies evaluating immunohistochemical staining optimiza-
tion, we did not find that the staining reaction for CD34 depended
on fixation times. The storage period of the paraffin blocks is not
likely to influence the immunostaining of vessel profiles. After
initial staining in a pilot sample with FVIII-ra, CD31, and CD34,
we decided to use CD34, because it stained more microvessel
profiles than FVIII-ra. In practice, antibodies to CD31 could prob-
ably be used as well, though they occasionally stain inflammatory
cells. Using an automated immunostainer further reduced the
variation due to laboratory techniques.
Prognostic value
The study showed that the vascular grade had an independent
prognostic value regarding both RFS and OS. We believe that we
can infer the results to the general population, because we had a
predefined sampling of the study population with few missing
data, a long follow-up, and a sufficient number of events. The
differences in survival probabilities for the patients with different
vascular grades were not likely to be due to treatment, since the
treatment was given within each group of vascular grade to the
same proportion of patients as in the entire study population,
indicating no association with the vascular grade from any of the
treatment modalities.
The role of angiogenesis as a prognosticator has been evaluated
in many series of patients with breast cancer (Fox, 1997); it has
been reported to have both prognostic value and the contrary. The
difficulties in extracting meaningful information from the litera-
ture regarding the prognosis are not confined to conflicting results;
they come mostly from the different techniques applied and the
uncertainty about the selection of the study populations, as demon-
strated by the heterogeneous composition of published studies. In
our study we accentuate the high quality of the study population
sample. This was achieved by a population-based identification of
the patients.
Angiogenesis in relation to the NPI
The NPI has been recommended for selecting patients for individ-
ualized adjuvant treatments according to the assigned prognostic
group (Galea et al, 1992). The reason for using the NPI in our
study was to have predefined validated prognostic criteria for
making therapeutic decisions. These plain criteria are chosen,
because decisions about advice and adjuvant treatment may differ
from department to department due to other factors such as predic-
tive factors, expectation about local control, or even personal pref-
erences. The vascular grade is not supposed to replace the NPI,
since the prognostic information is independent of and additive to
the basic prognostic variables included in the NPI. Inclusion in the
NPI of the prognostic value derived from the vascular grade would
change the prognostic risk estimate for many patients in our study;
for 24% of them to the extent that the NPI-based decision about
advice and adjuvant treatment would be changed. The survival
probability curves have a broader spread after the re-stratification
based on incorporation of the vascular grade into a combined
prognostic index. This better distinction of the prognosis demon-
strates the clinical relevance of the vascular grade.
In conclusion, vascular grading is a fast and easy-to-perform
estimate of angiogenesis, likely to be acceptable to pathologists in
general, but the reliability of the estimate is no better than other
methods assessing angiogenesis from hot-spot. Loss of informa-
tion due to the classification of the variable may be possible. This
moderate reliability may be accepted, if the prognostic value is
strong. Angiogenesis determined by vascular grade has indepen-
dent prognostic value of clinical relevance for patients with breast
cancer. The strong prognostic value of the vascular grade
advocates for the possibility of clinical implementation, although a
confirmatory study must be carried out. The vascular grading is
influenced not only by the number of vessel profiles, but also the
area of the vessel profiles. Future research on angiogenesis
methods should look upon more objective classification criteria
including the surface density and the volume density of the
vessels, and the importance of the mean area of the single vessel
profile. Objective classification criteria would facilitate the
acceptability of the scoring system, but the cost and time
consumption of complicated methodological readings would not
be beneficial for clinical diagnostic use.
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